Showing 20 of 68 recruiting trials for “limited-systemic-sclerosis”
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
👨⚕️ Caitlin Elgarten, MD, Children's Hospital of Philadelphia📍 1 site📅 Started Mar 2026View details ↗
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
RecruitingNCT07256418 ↗
Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma
A Study of AZD0120 in Autoimmune Diseases
Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
👨⚕️ Andreea Bujor, MD, PhD, BU Chobanian & Advesian School of Medicine📍 1 site📅 Started Nov 2025View details ↗
Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma
RecruitingNCT07182981 ↗
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
RecruitingNCT07182968 ↗
Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire
RecruitingNCT07183072 ↗
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
👨⚕️ Michael Saddekni, M.D., PgDip, BCMAS, Artiva Therapeutics📍 26 sites📅 Started Jul 2025View details ↗
RecruitingNCT07491523 ↗
Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）
👨⚕️ Zhu Chen, MD, The First Affiliated Hospital of University of Science and Technology of China📍 1 site📅 Started Mar 2025View details ↗
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
👨⚕️ JING XUE, PhD, Second Affiliated Hospital, School of Medicine, Zhejiang University📍 9 sites📅 Started Jan 2025View details ↗
Page 1 of 4Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →